VA patients get better chronic, preventive care than similar US adults

Patients enrolled in the Department of Veterans Affairs (VA) health system are significantly more likely than similar patients in the general population to receive preventive and chronic care recommended by well-established national standards, according to a new study released today in the Annals of Internal Medicine.

Researchers with VA; the RAND Corporation; the University of California, Los Angeles; and the University of Michigan compared the medical records of VA and non-VA patients and evaluated how effectively health care is delivered for acute, chronic and preventive care for 26 medical conditions.

The study found that:

  • Overall, VA patients received 67 percent of recommended care compared with 51 percent in the national sample.
  • Performance in the VA health system outpaced the national sample for chronic care; 72 percent of indicated chronic care was delivered to VA patients compared with 59 percent in the national sample.
  • Quality of preventive care, such as pneumococcal vaccination and screening for colorectal cancer, showed even greater differences; 64 percent of indicated preventive care was delivered to VA patients compared with 44 percent in the national sample.
  • Generally, VA patients received consistently better care across the entire spectrum of care, including screening, diagnosis, treatment and follow-up.
  • Quality of care for acute conditions was similar across both study populations.

The study compared the quality of outpatient and inpatient care between a national sample of patients drawn from 12 communities representative of metropolitan areas with populations of 200,000 or more and a sample of VA patients from 26 facilities in 12 health care systems located in the Southwestern and Midwestern United States. It assessed 348 clinical indicators of quality for the 26 acute and chronic conditions such as urinary tract infections, diabetes, asthma, high blood pres


Page: 1 2 3

Related biology news :

1. Abnormal fat metabolism underlies heart problems in diabetic patients
2. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
3. Aggressive therapy best for certain AML patients
4. Investigating antibiotic use in acute care patients
5. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
6. Co-operation between GSF and clinic improves outlook for sarcoma patients
7. Skin rash actually signifies better outcomes for pancreatic and lung cancer patients
8. Study examines cause of hearing loss for patients with certain genetic disease
9. Stem cell procedure successfully treats amyloidosis patients
10. New research holds promise for protecting cancer patients against infertility
11. Europe struggles to meet the challenges posed by PGD patients travelling abroad

Post Your Comments:

(Date:8/26/2020)... ... August 25, 2020 , ... ... solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ... PEGS Boston Virtual Conference & Expo, taking place between Aug. 31 – September ...
(Date:8/21/2020)... ... August 19, 2020 , ... “How can ... businesses dedicated to Salivary Bioscience for more than twenty years. Together with Douglas ... Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ," and ...
(Date:8/12/2020)... , ... August 12, 2020 , ... ... monitoring systems that are ideal for public health agencies of all sizes. With ... diseases and helping at-risk individuals find appropriate health care, Mosio helps public health ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... MIAMI (PRWEB) , ... July 29, 2020 , ... ... nearly 200 of the top radiation centers in 16 countries, has reached its ... years, SDX® is now in routine use at top universities including University of ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed ... Manager Regulatory Solutions, in a one hour live webinar on Thursday, August ... in China for drugs and medical devices. Specifically, for medical devices, the NMPA has ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new ... only technology of its kind on the market and we were pleased that the ... capacity of traditional cultured ingredients, creating a natural way to extend the shelf life ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , a leading ... food industries, is pleased to announce that Charles Galea has joined its clinical ... Charles is an accomplished and results-driven sales executive with over 10 years of ...
Breaking Biology Technology:
Cached News: